Dr. Reddy's API Manufacturing Capabilities:
Dr. Reddy’s manufactures over 250+ APIs across India, Mexico, and the UK, with eight USFDA-inspected cGMP facilities that comply with ICH Q7 guidelines and are regularly audited by global regulators. With 40+ years of expertise, the company specializes in complex APIs such as steroids, peptides, long-chain molecules, and HPAPIs, supported by robust R&D and worldwide commercialization capabilities.
Focused on becoming the leading global API company, Dr. Reddy’s emphasizes innovation, a strong global footprint, and exceptional customer service. With multi-sourced KSMs, stringent quality standards, timely deliveries, and capacity expansion, the company ensures a reliable, sustainable supply chain, combining scientific expertise, compliance, and sustainability to be a trusted API partner.

Loading manufacturing data...

Quality Control Policies
A key component in quality control in pharmaceutical industry is helping customers by providing a quality product. We achieve this by ensuring that all our facilities operate efficiently and to the latest quality, safety, and productivity standards.
At Dr. Reddy’s, quality control is central to our commitment to delivering safe, high-quality APIs. Our facilities operate under cGMP (ICH Q7) standards, ensuring global regulatory compliance and consistent product performance.
Advanced Analytical & Process Excellence
- Scalable manufacturing for consistent quality
- Robust analytical methods to eliminate nitrosamine and azido impurities
- Comprehensive impurity profiling, characterization, and control
- Use of advanced techniques to define chemical and physical attributes
- Efficient operations aligned with the latest quality, safety, and productivity standards
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.









